Aldo Scarpa

This study identifies three distinct spliceosomic profiles in pancreatic neuroendocrine tumors linked to clinical and molecular characteristics and potential therapeutic targets.

This study traces the clonal evolution of pancreatic cancer from IPMN using genomic and transcriptomic data, identifying two distinct evolutionary trajectories and their implications for PDAC progression.

This study profiles proteins and glycoproteins in pancreatic neoplasms to identify expression patterns and potential progression markers.

This study identifies EIF4A3 as an oncogenic factor in PDAC by showing its overexpression correlates with poor prognosis and its role in regulating RNA splicing and tumor growth.

The paper uses a multi-layered approach combining GWAS, spatial autocorrelation, and Hi-C to identify novel genetic variants associated with pancreatic cancer susceptibility.

The paper classifies epithelial cancers into five heterocellular subtypes, revealing previously unrecognized heterogeneity and identifying tissue-independent properties across cancer types.